Document:

exhibit_10-1.htm

Exhibit 10.1

CONSULTING AGREEMENT

THIS CONSULTING AGREEMENT (this “agreement”) is made as of July 1, 2014 by and between New York Global Innovations, Inc., and its wholly owned subsidiaries (collectively the ACompany@) and Gilat Technologies (in formation), a company organized under the laws of the State of Israel with offices located at 8 Rachel Street, Givatayim, (the AConsultant@).

W I T N E S S E T H

WHEREAS, the Company desires to retain the Consultant, and the Consultant desires to consult with the Company and its successors, in order to make use of such expertise, know-how and experience which the Consultant possesses with respect to the Company.

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements hereinafter set forth, the parties, intending to be legally bound, agree as follows:

1.           Term.  The Company (including, for purposes of this Agreement, any affiliate) hereby retains the Consultant, and the Consultant hereby accepts such retention by the Company, on a month to month basis commencing July 1, 2014, subject to the terms and conditions hereinafter set forth (the “term”).  The Company and/or the Consultant shall have the right to terminate this Agreement for any reason whatsoever on thirty (30) days prior written notice.

2.           Consultant=s Duties and Responsibilities. During the Term the Consultant shall provide to the Company consulting services relating to the needs of the Company. The Consultant shall devote such time as mutually agreed to the affairs and business of the Company. It is understood and agreed that Consultant need not spend more than 20% of his working time to the Company and may act as a consultant to other companies as well as the Company.  The Consultant shall receive his assignments from the Board of Directors and shall act as acting CEO of the Company.  In performing its duties hereunder, the Consultant shall make Tal Gilat available to perform its duties hereunder.

(a)         Board of Directors.  Consultant shall assist the Company's Board of Directors as requested in finding suitable acquisitions and mergers for the Company.

3.           Compensation.  As compensation for his services hereunder the Consultant shall be paid as follows:

(a)         As compensation for his services hereunder the Company shall pay Consultant during the Term $3,000.00 per month plus VAT as required by Israeli law, against provision of a valid invoice (the “Basic Compensation”);

 

  

  

  

(b)         During the Term, upon submission of written statements and bills in accordance with the then regular procedures of the Company, Consultant shall be entitled to reimbursement for reasonable pre-approved out-of pocket expenses necessarily incurred in the performance of his duties hereunder, including, but not limited to, reimbursement for travel. A car and expenses will be provided monthly at the current monthly gross amount (monthly car leasing fee _+ monthly maximum gas allowance) plus VAT as required by Israeli law, against provision of a valid invoice

                4.          Termination.

 

(a)         This Agreement and the consulting services of the Consultant shall terminate upon the occurrence of any one or more of the following events:

(i)           the death or disability of the Consultant which would prevent the Consultant assisting the Company; or

 

(ii)           termination by the Company or Consultant in accordance with paragraph 1 hereof.

(b)         Upon the expiration or other termination of this Agreement, the Company shall reimburse the Consultant all reimbursable expenses owed under Section 3 (b) and all further obligations of the parties shall forthwith terminate, except for the obligations of the Consultant pursuant to Section 5 hereof.

 

               5.            Non-Disclosure.    Consultant acknowledges that he will be given access to confidential and proprietary information of the business of the Company.  The Consultant acknowledges that non-public confidential information gained by him on behalf of the Company is the proprietary information of the Company and, if used by him or disclosed to others other than on behalf of the Company, could cause competitive and irreparable harm to the Company.  Accordingly, the Consultant agrees to hold in a fiduciary capacity for the benefit of the Company all confidential information, knowledge or data (including customer lists) of the Company and any affiliate of the Company obtained by the Consultant (whether or not developed by the Consultant) which is not generally known to the public (other than as a result of disclosures by the Consultant) and will not, whether during the Term or thereafter, communicate or divulge any such information, knowledge or data to any person, firm or corporation, other than to the Company or persons, firms or corporations designated by the Company, or use any such information, knowledge or data for his own account or the account of anyone other than the Company.  During the Term the Consultant agrees to refrain from working with a competitor to the Company.

6.           Independent Contractor; Waiver of Liability.  During the Term the Consultant at all times will be an independent contractor and not an agent or employee of the Company.

 

  

- 2 -

  

7.           Severability.  To the extent any provision of this Agreement shall be invalid or unenforceable, it shall be considered deleted herefrom and the remainder of such provision and of this Agreement shall be unaffected.

8.           Governing Law.  This Agreement is made under and shall be governed by and construed in accordance with the laws of the State of New York without regard for its principles concerning conflicts of law.

9.           Successors.  This Agreement shall extend to and be binding upon the Consultant, and upon the Company, its successors and assigns.

10.         Amendments.  No amendment or modification of this Agreement shall be deemed effective unless made in writing signed by the parties hereto.

11.         No Waiver.  No term or condition of this Agreement shall be deemed to have been waived, nor shall there be any estoppel to enforce any provision of this Agreement, except by a statement in writing signed by the party against whom enforcement of the wavier or estoppel is sought.  Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

12.         Headings.  The headings of paragraphs in this Agreement are solely for convenience of reference and shall not control the meaning or interpretation of any provisions of this Agreement.

13,         Termination of Employment Agreement.  It is understood and agreed that the Employment Agreement between the Company and Consultant dated March 7, 2010 is hereby terminated and of no further force or effect.  Each party hereto confirms that each party has performed all of their obligation thereunder to the other and no further performance by any party is required.

IN WITNESS WHEREOF, the parties have duly executed this Agreement on the day and year specified above.

 

	 	

NEW YORK GLOBAL INNOVATORS, INC.

	 
	 	 	 	 
	
 

	
By: 

	/s/ Gadi Peleg	 
	 	 	Gadi Peleg, Chairman	 
	 	 	 	 

	 	

GILAT TECHNOLOGIES

	 
	 	 	 	 
	
 

	
By: 

	/s/ Tal Gilat,  	 
	 	 	Tal Gilat, Managing Director and President	 
	 	 	 	 
	 	 	 	 

 

- 3 -Exhibit 10.1

 

CONFIDENTIAL SETTLEMENT AGREEMENT AND
MUTUAL RELEASE

 

This Confidential Settlement
Agreement and Mutual Release (this “Agreement”), is made July 10, 2014 (the “Effective Date”), between
Cyalume Technologies, Inc., (“Cyalume”) and Cyalume on behalf of Emil Jachmann (“Jachmann”), in the first
instance, and Omniglow LLC, (“OmniGlow”), Randye M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland
and Stanley M. Holland Trust and the Leemon Family LLC, in the second instance, (individually sometimes referred to as a “Party”
and collectively as the “Parties”).

 

RECITALS

 

A.WHEREAS, on January
23, 2006, Cyalume and OmniGlow entered into various written agreements. Subsequently, disputes arose between the Parties and lawsuits
were filed.

 

B.WHEREAS, on or
about June 29, 2006, OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland and Stanley M. Holland
Trust, the Leemon Family LLC, and Achaian, Inc. filed Civil Action No. 06-706 in the Superior Court of Hampden County, Massachusetts
alleging that Cyalume and Jachmann breached agreements and engaged in conduct which caused damage to OmniGlow. Subsequently, Cyalume
and Jachmann filed their Answer With Counterclaims denying the Hampden Superior Court civil action allegations and alleging that
OmniGlow breached agreements and engaged in conduct which caused damage to Cyalume.

 

C.WHEREAS, on or
about October 5, 2006, Cyalume filed Civil Action No. 603512/06 in the New York Supreme Court of New York County alleging, among
other things, that OmniGlow and its officers, including Ira Leemon and Stanley Holland, breached agreements which caused damage
to Cyalume. Subsequently, on Motion by OmniGlow, that civil action was stayed pending the outcome of Hampden Superior Court Civil
Action No. 06-706 in Massachusetts.

 

    	 

    	 

    

 

D.WHEREAS, on July
12, 2012, an Amended Final Judgment was filed in Hampden Superior Court Civil Action No. 06-706 awarding damages to OmniGlow including
attorneys’ fees, costs, and prejudgment interest (“Amended Final Judgment”).

 

E.WHEREAS, on or
about October 17, 2012, Cyalume, on its and Jachmann’s behalf, filed Defendants’ Notice of Appeal from Hampden Superior
Court Civil Action No. 06-706 in the Massachusetts Appeals Court, which assigned the Docket No. 2013-P-0280.

 

F.WHEREAS, on May
14, 2014, the Appeals Court issued its decision in case No. 2013-P-0280, which upheld the July 12, 2012 Amended Final Judgment.

 

G.WHEREAS, on July
1, 2014, Cyalume, on its and Jachmann’s behalf, filed an Application For Further Appellate Review in the Massachusetts Supreme
Judicial Court, which application is still pending as Docket No. FAR-22600.

 

H.WHEREAS, the
Parties have reached an agreement and wish to settle, compromise and resolve, throughout the universe and in perpetuity, all claims
past and present, under the laws of any territory, country or jurisdiction, based on or related to Hampden Superior Court Civil
Action No. 06-706, New York Supreme Court Civil Action No. 603512/06, Massachusetts Appeals Court Docket No. 2013-P-0280, and Massachusetts
Supreme Judicial Court Docket No. FAR 22600 (collectively hereafter the “Civil Claims”), each Party to bear its own
attorneys’ fees and costs.

 

In consideration of
the Recitals, the mutual covenants and agreements set forth herein, and other good and valuable consideration, the sufficiency
and receipt of which they hereby acknowledge, the Parties agree as follows:

 

    	2

    	 

    

 

1.Recitals.
The foregoing Recitals are incorporated into and form a part of this Settlement Agreement.

 

2.No Admissions.
This Settlement Agreement is entered into for the purposes of settling disputes between the Parties. Nothing contained in this
Settlement Agreement shall be considered an admission of wrongdoing or liability by either party of any kind or nature whatsoever.
Each party specifically denies wrongdoing.

 

3.Settlement
Payment. Cyalume shall either:

 

a.pay the settlement
amount of $4,547,851.47 (“Settlement Amount”); OR

 

b.make an initial
good faith payment of $250,000 to OmniGlow on July 10, 2014, by wire transfer to: “CitiBank, Acct. No. 35354087, ABA No.
021000089.” Within 21 days from the execution of this Agreement, Cyalume shall make an additional down payment of
One Million Dollars ($1,000,000.00) payable Six Hundred Twenty-five Thousand Dollars ($625,000.00) to Stanley Holland by wire transfer
to “Wells Fargo, Acct. No. 0264433509, ABA No. 121000248” and Three Hundred Seventy-five Thousand Dollars ($375,000.00)
to OmniGlow by wire transfer. In addition, within 14 days from the execution of this Agreement, Cyalume shall transfer 625,139
shares of Cyalume stock, one-half to Holland and one-half to OmniGlow. Further, Cyalume may fully satisfy the remaining balance
due on the Settlement Amount by either making additional payments by cash and/or through cooperative manufacturing credits of (i)
One Million Nine Hundred Thousand Dollars ($1,900,000.00) in cash or credits if paid and received by OmniGlow within eighteen (18)
months from the Effective Date of this Agreement, or (ii) Two Million Three Hundred Fifty Thousand Dollars ($2,350,000.00) in cash
or credits if paid and received by OmniGlow within twenty seven (27) months from the Effective Date of this Agreement. If Cyalume
fails to fully satisfy the payment obligation on the Settlement Amount through 2(b)(i) or 2(b)(ii), then after twenty seven (27)
months from the Effective Date, any balance remaining from the Settlement Amount will be due and payable plus accrued interest
at simple interest rate of 10% per annum (“Interest Rate”) on the unpaid balance (Settlement Amount less all payments
made from the Effective Date forward) from the Effective Date until paid in full and OmniGlow can use all available remedies
to obtain payment of any balance. In order to avoid any confusion regarding the interest calculation described in the preceding
sentence, an example is provided as follows for illustration purposes only: From the Effective Date, the remaining balance would
be $4,297,851.47, reflecting $250,000 good faith payment to OmniGlow. This remaining balance will accrue interest at the Interest
Rate until next payment. Upon payment of an additional $1,000,000 by Cyalume, the remaining balance will be reduced to $3,297,851.47
and this remaining balance will accrue interest at the Interest Rate from the date of the $1,000,000 payment until further payments
and so and so forth until the Settlement Amount is fully satisfied through the payment options included herein.

 

    	3

    	 

    

 

4.Standstill
and Stay of Enforcement of Amended Final Judgment. So long as Cyalume is in compliance with its obligations in this Agreement
and not otherwise in breach of this Agreement, OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M.
Holland and Stanley M. Holland Trust and the Leemon Family LLC shall take no action in connection with the Amended Final Judgment
unless and until Cyalume files a petition in bankruptcy; or Cyalume makes an assignment for the benefit of creditors; or a court
appoints a receiver, custodian or trustee for Cyalume or its assets; or an actual petition in bankruptcy is commenced; or Cyalume
files for dissolution or a court dissolves Cyalume; or Cyalume completely or substantially ceases operations; or Cyalume Defaults
on any substantial bank loan or line of credit that is not cured or waived or otherwise becomes subject to forbearance within 90
days. OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland and Stanley M. Holland Trust, and
the Leemon Family LLC further agree to stay any and all proceedings concerning the Civil Claims and Amended Final Judgment. To
the extent any Court(s) require(s) filings codifying the standstill and/or stay agreements contemplated by this paragraph, the
Parties shall file same jointly.

 

    	4

    	 

    

 

5.Satisfaction
of Amended Final Judgment. Within three (3) business days of Cyalume’s satisfaction of paragraph 3 above, OmniGlow, Randye
M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland and Stanley M. Holland Trust and the Leemon Family LLC,
and Achaian, Inc. shall file with the Hampden Superior Court, a document indicating that Cyalume and Jachmann have satisfied the
amounts due under the Amended Final Judgment in full.

 

6.Cooperative
Agreements.

 

a.OmniGlow and Cyalume acknowledge and
agree that cooperative agreements may be mutually beneficial. OmniGlow and Cyalume will endeavor to enter into a cooperative manufacturing
and chemical supply agreement at mutually agreeable terms.

 

b.If both OmniGlow and Cyalume are able
to identify and mutually agree upon realizable cost savings (“Cost Savings”), OmniGlow and Cyalume will endeavor to
enter into one or more cooperative manufacturing agreements, subject to mutual agreement on terms by the Parties. Cost Savings
is defined as Cyalume’s all-in manufacturing cost per product less OmniGlow’s comparable manufacturing cost. The products
to be chosen for the cooperative manufacturing will be at Cyalume’s sole discretion. If OmniGlow and Cyalume mutually agree
to proceed with one or more cooperative manufacturing agreements, then the Cost Savings will be shared between the Parties as follows:
(i) 80/20 for OmniGlow and Cyalume, respectively, until OmniGlow receives what it is owed in Section 3 above, and (ii) 50/50 for
OmniGlow and Cyalume, respectively, thereafter. The initial term for the cooperative agreements between the parties will be 3 years
with any extension to be mutually agreed upon in writing prior to the expiration of three (3) years.

 

    	5

    	 

    

 

c.If both OmniGlow and Cyalume are able
to identify and mutually agree upon chemistry that Cyalume has available or can supply to OmniGlow, Cyalume and OmniGlow will endeavor
to enter into a chemical supply agreement at mutually agreeable terms.

 

d.In the event that OmniGlow and Cyalume
are not able to reach a mutual agreement contemplated by this paragraph, neither party will be subject to any liability from any
failure to reach a mutually satisfactory cooperative agreements.

 

7.Non-Competition.

 

a.All existing
non-compete agreements that Cyalume and all its affiliates and subsidiaries are currently bound to will be terminated.

 

b.If Cyalume and
OmniGlow are able to reach a mutual cooperative agreements for the manufacturing of products and supply of chemistry, then Cyalume
and OmniGlow will endeavor to agree upon a reasonable non-competition agreement

 

c.In the event
that OmniGlow and Cyalume are not able to reach a mutually agreeable non-competition agreement contemplated by this paragraph,
neither party will be subject to any liability from any failure to reach such agreement.

 

8.Settlement
and Release of Civil Claims.

 

a.Upon receipt
of the full amount due under paragraph 3 above, OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M.
Holland and Stanley M. Holland Trust and the Leemon Family LLC and their respective successors and assigns, officers, directors,
members, stockholders, partners, agents, servants, employees, insurers, attorneys and representatives release, acquit and forever
discharge Cyalume and all of its successors and assigns, officers, directors, members, stockholders, partners, agents, servants,
employees, insurers, attorneys and representatives from any and all disputes, damages, actions, liabilities, attorneys’ fees,
costs, demands and any other claims, including the Civil Claims, known or unknown, suspected or unsuspected, arising out of, relating
to or in any way connected with the Civil Claims and Amended Final Judgment (collectively, the “Cyalume Released Claims”),
but not the obligations in or arising from this Agreement.

 

    	6

    	 

    

 

b.Upon execution
of this Agreement, Cyalume and its successors and assigns, officers, directors, members, stockholders, partners, agents, servants,
employees, insurers, attorneys and representatives release, acquit and forever discharge OmniGlow, Randye M. Holland and Stanley
M. Holland as Trustees of the Randye M. Holland and Stanley M. Holland Trust, and the Leemon Family LLC and all of their respective
successors and assigns, officers, directors, members, stockholders, partners, agents, servants, employees, insurers, attorneys,
and representatives from any and all disputes, damages, actions, liabilities, attorneys’ fees, costs, demands and any other
claims, including the Civil Claims, known or unknown, suspected or unsuspected, arising out of, relating to or in any way connected
with the Civil Claims (collectively, the “Omniglow Released Claims”), but not the obligations in or arising from this
Agreement. Further, this provision has no impact on claims made by Cyalume in New York Supreme Court Civil Action No. 603512/06
against any defendants (other than OmniGlow, Ira Leemon and Stanley Holland). Cyalume’s claims in that suit against the defendants
(other than OmniGlow, Ira Leemon and Stanley Holland). survive this Agreement.

 

    	7

    	 

    

 

		9.	Ira Leemon’s Indemnification of Cyalume and Jachmann. 

 

Ira Leemon agrees to
hold harmless and indemnify Cyalume and Jachmann of and from any claims, demands, disputes, suits and / or causes of action asserted
by Achaian against them, and any related costs (including their attorneys’ fees and action / litigation related expenses),
damages and / or other liabilities.

		10.	Representations and Warranties of Cyalume.

 

As of the Effective
Date, Cyalume represents and warrants to OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland
and Stanley M. Holland Trust and the Leemon Family LLC that:

 

a.Cyalume has full
power, authority and capacity to execute and deliver this Agreement (including on behalf of Jachmann) and consummate the transactions
contemplated by this Agreement;

 

b.when duly executed
and delivered, this Agreement shall constitute the legal, valid and binding obligation of Cyalume and shall be enforceable against
Cyalume in accordance with its terms;

 

c.the execution
and delivery of this Agreement by Cyalume does not, and the consummation of the transactions contemplated hereby will not constitute
a default under or a violation or breach of, or result in the acceleration of any obligation under, any provision of any contract
or other instrument to which Cyalume is a party;

 

Cyalume has not created or permitted
any security interest to exist in connection with the OmniGlow Released Claims (as defined in paragraph 8 above) including the
Civil Claims, has not sold or transferred the OmniGlow Released Claims including the Civil Claims, has not mortgaged, pledged,
or otherwise encumbered the OmniGlow Released Claims including the Civil Claims, and has the sole and absolute right to release,
extinguish and discharge the OmniGlow Released Claims including the Civil Claims, and will not file any application, petition,
appeal or take any action to amend, modify, or discharge the Amend Final Judgment (other than those appellate filings already a
matter or record).

 

    	8

    	 

    

 

		11.	Representations and Warranties of OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees
of the Randye M. Holland and Stanley M. Holland Trust, the Leemon Family LLC, and Achaian, Inc.

 

As of the Effective
Date, OmniGlow, Randye M. Holland and Stanley M. Holland as Trustees of the Randye M. Holland and Stanley M. Holland Trust and
the Leemon Family LLC represent and warrant to Cyalume and Jachmann that:

 

a.They have full
power, authority and capacity to execute and deliver this Agreement and consummate the transactions contemplated by this Agreement;

 

b.when duly executed
and delivered, this Agreement shall constitute the legal, valid and binding obligation of each of them and shall be enforceable
against each of them in accordance with its terms;

 

c.the execution
and delivery of this Agreement by them does not, and the consummation of the transactions contemplated hereby will not constitute
a default under or a violation or breach of, or result in the acceleration of any obligation under, any provision of any contract
or other instrument to which they are a party;

 

d.they have not
created or permitted any security interest to exist in connection with the Cyalume Released Claims (as defined in paragraph 8 above)
including the Civil Claims and the Amended Final Judgment, have not sold or transferred the Cyalume Released Claims including the
Civil Claims and the Amended Final Judgment, have not mortgaged, pledged, or otherwise encumbered the Cyalume Released Claims including
the Civil Claims and the Amended Final Judgment, and have the sole and absolute right to release, extinguish and discharge the
Cyalume Released Claims including the Civil Claims and Amended Final Judgment.

 

    	9

    	 

    

 

12.No Inducement.None
of the Parties, nor any of their respective attorneys, officers, agents, directors, or employees, or any of them, has made any
promise, representation, or warranty whatsoever, express or implied, to induce any other Party to execute this Agreement, and the
Parties acknowledge that they have not executed this Agreement in reliance upon any promise, representation or warranty other than
those which appear in this instrument. Without limiting the foregoing, no representation or warranty, express or implied, is made
by Cyalume or OmniGlow regarding the tax consequences of this Agreement. Cyalume and OmniGlow each expressly acknowledges that
it is solely responsible for any tax payment obligations resulting from payments under paragraph 3 above, any additional interest
or late payment charges, and/or this Agreement.

 

13.Confidentiality.
The Parties and their employees, agents, boards / board members and attorneys agree that this Agreement and its terms are and shall
be kept confidential by the Parties and their employees, agents, boards / board members and attorneys. Except as set forth above;
and except to the extent reasonably necessary to enforce the Agreement; or to the extent that either of the Parties reasonably
believes it is required by law to disclose certain of the terms of this Agreement; or to the extent that either of the Parties
is required to disclose the terms of its individual settlement to the taxing authorities, preparers or others with respect to tax
matters; or to the extent required by subpoena or other order of a court or government body of competent jurisdiction, the terms
and conditions of this Agreement, including the amounts of payment, shall remain confidential and shall not be disclosed. To the
extent required by subpoena or other written order, rule, or regulation of a court or government body of competent jurisdiction,
the party being compelled to provide the information will notify the other party via their counsel of record within five (5) business
days of receipt of the subpoena or written order.

 

14.Non-Disparagement.The Parties agree that none of them will
make nor cause to be made any statements that disparage, defame or intentionally damage the reputation of each other (or any members,
managers, officers, directors, employees, agents, representatives, predecessors and successors in interests, stockholders, investors,
affiliates, parents, subsidiaries, servants, boards / board members or attorneys of the other, where applicable).

 

    	10

    	 

    

 

15.Entire
Agreement.This Agreement constitutes the entire agreement and understanding between the Parties concerning the
subject matter hereof and supersedes any and all prior or contemporaneous agreements, understandings or negotiations, whether
written or oral, between the Parties that refer or relate to this Agreement. This Agreement can be modified only in a writing
executed by the Parties that expressly states that it is a modification of this Agreement. No provision hereof may be waived
unless in writing and signed by the Party whose rights are thereby waived. Waiver of one provision hereof shall not be deemed
to be a waiver of any other provision hereof.

 

16.Binding on
Successors and Others. This Agreement is and shall be binding upon and inure to the benefit of the Parties hereto and their
respective officers, directors, shareholders, members, divisions, parent companies, subsidiary companies, affiliated companies,
agents, employees, representatives, attorneys, relatives, spouses, beneficiaries, heirs, executors, administrators, assigns, predecessors
in interest, successors in interest and all other persons and entities released hereunder.

 

    	11

    	 

    

 

17.Attorneys’
Fees. Each Party to this Agreement shall be responsible for its own attorneys’ fees and costs incurred in connection
with Hampden Superior Court Civil Action No. 06-706, New York Supreme Court Civil Action No. 603512/06, Massachusetts Appeals Court
Docket No. 2013-P-0280 and Massachusetts Supreme Judicial Court Docket No. FAR 22600, including without limitation, the negotiation
and execution of this Agreement.

 

18.Governing
Law and Forum. This Agreement and the obligations and rights of the Parties hereunder shall be governed by, and construed in
accordance with, the laws of the Commonwealth of Massachusetts (regardless of any conflict of laws principles). Subject to the
applicable law, the Parties agree that a final determination/ruling in any JAMS arbitration (as provided for in paragraph 26) arising
out of or relating to this Agreement shall be conclusive and may be enforced in any other jurisdiction within or outside the United
States by suit on the final determination/ruling, a certified copy of which final determination/ruling shall be conclusive evidence
thereof and the amount of its indebtedness, or by such other means provided by law.

 

19.Tax Consequences;
No Representations or Warranties. The Parties each acknowledges and agrees that it shall separately be responsible for any
tax obligations or consequences resulting from the terms or enforcement of the terms of this Agreement. The Parties acknowledge
and agree that they have not made any representations or warranties concerning the tax obligations or consequences arising out
of this Agreement and that there are no representations or warranties of any kind concerning the tax obligations or consequences
arising out of this Agreement.

 

20.Independent
Advice of Counsel. The Parties each represents that it has carefully read this Agreement, knows its contents, and understands
that its terms are contractual and not mere recitals. The Parties further represent that each has had the advice of counsel of
its choosing and has signed this Agreement freely and voluntarily; and has not been influenced to any extent whatsoever in doing
so by any representations, statements or promises made other than as set forth in this Agreement.

 

    	12

    	 

    

 

21.Construction
and Interpretation. The headings of the paragraphs of this Agreement are for convenience of reference only and shall not affect
the meaning or interpretation of this Agreement or any provision hereof. The use of the neuter form herein shall be deemed to include
the masculine and feminine forms, as the context may require. The terms “and,” “or” and “and/or”
shall be construed conjunctively, disjunctively, or both, as necessary to give the provisions of this Agreement their broadest
and most inclusive scope. The Parties acknowledge, warrant and represent that the Parties and their counsel have each participated
in the drafting of this Agreement and each provision hereof, that the Agreement shall be construed as a whole according to its
fair meaning, and that the Agreement shall not be construed or interpreted against any Party because a provision or the Agreement
as a whole was purportedly prepared, drafted or requested by such party.

 

22.Implementation.
The Parties agree to execute such other documents, if any, and to provide reasonable cooperation as necessary to carry out the
intent of this Agreement. Each Party hereto agrees that such party will not take any action which would interfere with the performance
of this Agreement by any other Party hereto or which would adversely affect any of the rights or benefits provided herein.

 

23.Authority. Each
individual signing this Agreement warrants and represents that he or she has full right, power, legal capacity and authority
to execute this Agreement on behalf of the Party on whose behalf he or she so signs, that he or she is acting within the
scope of such authority with the full knowledge and consent of such Party, and that no further approval or consent of
any person, board of directors, partner or other entity is necessary for him or her to execute this Agreement and bind the
Party to the terms of the Agreement.

 

    	13

    	 

    

 

24.Counterparts.
This Agreement may be executed in one or more counterparts (including multiple signature pages), each of which shall be deemed
an original and all of which shall be deemed one instrument. Facsimile and photocopy signatures shall be binding and effective
and shall have the same force and effect as original signatures. True and correct copies may be used in lieu of the original.

 

25.Fees and
Costs of Enforcement. Should any Party retain an attorney for the purpose of enforcing or construing this Agreement, in any
JAMS arbitration, enforcement proceeding or legal proceeding whatsoever, that Party shall be entitled to receive from the non-prevailing
Party reimbursement for all reasonable attorneys’ fees and all reasonable costs, including but not limited to service of
process, filing fees, court and court reporter costs, investigative costs, expert witness fees, and reimbursement for all reasonable
attorneys’ fees and all reasonable costs shall be included in any final determination or final order issued in the subject
arbitration, enforcement action or legal proceeding.

 

26.Dispute Resolution.
The Parties agree to resolve any dispute arising from this Agreement by arbitration in Springfield, Massachusetts in the English
language before a single arbitrator in accordance with the then current Streamlined Arbitration Rules of JAMS, and judgment on
the award rendered by the arbitrator may be entered in the United States District Court of the District of Massachusetts. The Parties
will pay equal shares of the arbitrator’s fees and any administrative fees but will otherwise bear their own expenses. The
arbitrator will have discretion to award any damages available under applicable law. Except for any stenographer and the arbitrator,
attendance at the arbitration will be limited to the Parties and their counsel and witnesses. Except as necessary for purposes
of an action to enforce, modify, or vacate the arbitration award, the subject matter of the arbitration, all documents and other
information submitted to the arbitrators, including any transcript of the proceedings and any award, will be treated as Confidential
Information.

  

**SIGNATURES ON FOLLOWING PAGE**

 

    	14

    	 

    

 

IN WITNESS WHEREOF,
the Parties hereto have signed this Agreement as of the date and at the place first above written.

 

	CYALUME TECHNOLOGIES INC.	 	OMNIGLOW, LLC
	 	 	 	 	 
	By:	/s/ Zivi Nedivi	 	By:	/s/ Ira Leemon
	 	 	 	 	 
	Name:	Zivi Nedivi	 	Name:	Ira Leemon
	 	 	 	 	 
	Title:	Chief Executive Officer	 	Title:	President
	 	 	 	 	 
	RANDYE M. HOLLAND AND 	 	THE LEEMON FAMILY LLC
	STANLEY M. HOLLAND TRUST	 	 	 
	 	 	 	 	 
	By: 	/s/ Stanley M. Holland 	 	By:	/s/ Ira Leemon
	 	 	 	 	 
	Title:	Trustee, Stanley M. Holland	 	Title:	Manager
	 	 	 	 	 
	By: 	/s/ Randye Holland	 	 	 
	 	 	 	 	 
	Title:	Trustee, Randye Holland	 	 	 
	 	 	 	 	 
	IRA LEEMON, INDIVIDUALLY	 	 	 
	 	 	 	 	 
	/s/ Ira Leemon	 	 	 

 

    	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]